NLRP3 and lupus nephritis: NLRP3 inflammasome is activated in podocytes of patients with lupus nephritis and mice, and inhibition of NLRP3 by MCC950 attenuates proteinuria, renal pathological damage, and podocyte fusion in mice with lupus nephritis (Fu et al., 2017).